RAPT
Price
$20.96
Change
+$0.83 (+4.12%)
Updated
Sep 23 closing price
Capitalization
346.63M
SLGL
Price
$28.81
Change
+$0.80 (+2.86%)
Updated
Sep 23 closing price
Capitalization
80.26M
43 days until earnings call
Interact to see
Advertisement

RAPT vs SLGL

Header iconRAPT vs SLGL Comparison
Open Charts RAPT vs SLGLBanner chart's image
RAPT Therapeutics
Price$20.96
Change+$0.83 (+4.12%)
Volume$102.24K
Capitalization346.63M
Sol-Gel Technologies
Price$28.81
Change+$0.80 (+2.86%)
Volume$24.3K
Capitalization80.26M
RAPT vs SLGL Comparison Chart in %
Loading...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RAPT vs. SLGL commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RAPT is a Buy and SLGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (RAPT: $20.96 vs. SLGL: $28.81)
Brand notoriety: RAPT and SLGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RAPT: 86% vs. SLGL: 91%
Market capitalization -- RAPT: $346.63M vs. SLGL: $80.26M
RAPT [@Biotechnology] is valued at $346.63M. SLGL’s [@Biotechnology] market capitalization is $80.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RAPT’s FA Score shows that 0 FA rating(s) are green whileSLGL’s FA Score has 0 green FA rating(s).

  • RAPT’s FA Score: 0 green, 5 red.
  • SLGL’s FA Score: 0 green, 5 red.
According to our system of comparison, SLGL is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RAPT’s TA Score shows that 4 TA indicator(s) are bullish while SLGL’s TA Score has 3 bullish TA indicator(s).

  • RAPT’s TA Score: 4 bullish, 4 bearish.
  • SLGL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, RAPT is a better buy in the short-term than SLGL.

Price Growth

RAPT (@Biotechnology) experienced а +18.89% price change this week, while SLGL (@Biotechnology) price change was +19.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Reported Earning Dates

SLGL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAPT($347M) has a higher market cap than SLGL($80.3M). SLGL YTD gains are higher at: 209.752 vs. RAPT (65.823). SLGL has higher annual earnings (EBITDA): -4.59M vs. RAPT (-111.99M). RAPT has more cash in the bank: 169M vs. SLGL (24.3M). SLGL has less debt than RAPT: SLGL (1.18M) vs RAPT (3.16M). SLGL has higher revenues than RAPT: SLGL (23.9M) vs RAPT (0).
RAPTSLGLRAPT / SLGL
Capitalization347M80.3M432%
EBITDA-111.99M-4.59M2,440%
Gain YTD65.823209.75231%
P/E RatioN/AN/A-
Revenue023.9M-
Total Cash169M24.3M695%
Total Debt3.16M1.18M268%
FUNDAMENTALS RATINGS
RAPT vs SLGL: Fundamental Ratings
RAPT
SLGL
OUTLOOK RATING
1..100
2467
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
3534
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLGL's Valuation (52) in the Pharmaceuticals Major industry is in the same range as RAPT (77) in the null industry. This means that SLGL’s stock grew similarly to RAPT’s over the last 12 months.

SLGL's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as RAPT (100) in the null industry. This means that SLGL’s stock grew similarly to RAPT’s over the last 12 months.

SLGL's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as RAPT (100) in the null industry. This means that SLGL’s stock grew similarly to RAPT’s over the last 12 months.

SLGL's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as RAPT (35) in the null industry. This means that SLGL’s stock grew similarly to RAPT’s over the last 12 months.

SLGL's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as RAPT (100) in the null industry. This means that SLGL’s stock grew similarly to RAPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RAPTSLGL
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 26 days ago
90%
Bearish Trend 15 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NETTF30.451.40
+4.83%
NetEase, Inc.
DTNOF1.50N/A
N/A
DNO ASA
BKUT513.80N/A
N/A
Bank of Utica (NY)
CTYP6.16N/A
N/A
Community Bankers (PA)
NGKSY18.02N/A
N/A
NITERRA CO LTD.

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been loosely correlated with TRAW. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPT jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
+4.12%
TRAW - RAPT
45%
Loosely correlated
-1.57%
SLGL - RAPT
39%
Loosely correlated
+2.86%
CTMX - RAPT
35%
Loosely correlated
+2.43%
AVXL - RAPT
34%
Loosely correlated
-2.63%
PDSB - RAPT
32%
Poorly correlated
-2.78%
More

SLGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLGL has been loosely correlated with TRAW. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SLGL jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLGL
1D Price
Change %
SLGL100%
+2.86%
TRAW - SLGL
47%
Loosely correlated
-1.57%
RAPT - SLGL
39%
Loosely correlated
+4.12%
NEUP - SLGL
39%
Loosely correlated
+11.97%
CMND - SLGL
33%
Loosely correlated
-7.27%
AZTR - SLGL
33%
Poorly correlated
-2.61%
More